Silvia Galora

437 citations
9 papers · 158 indexed · h-index 7
Topics
Lipoproteins and Cardiovascular Health (3 papers)Antiplatelet Therapy and Cardiovascular Diseases (2 papers)Connective tissue disorders research (2 papers)
Partner nations
Italy

In The Last Decade

Silvia Galora

9 papers receiving 157 citations

Peers

Silvia Galora
Comparison fields: 5 of 59
  • Pulmonary and Respiratory Medicine 57
  • Cardiology and Cardiovascular Medicine 42
  • Surgery 33
  • Molecular Biology 31
  • Immunology 25
Replace Yu Hashimoto with:
Yu Hashimoto Japan
Mohamed Sami Mourali Tunisia
Robert Prosecký Czechia
Tymon Pol Sweden
M Mericliler Germany
Yang Su China
Weihua Zhang China
Nathaly Anto-Michel Germany
A Calafiore Italy
Elena Demicheva Germany
Silvia Galora relative to Yu Hashimoto Japan Yu Hashimoto's profile →
Citations per field
00.5×
Yu Hashimoto · 1×
Citations per year

Countries citing papers authored by Silvia Galora

Since Specialization
Citations

This map shows the geographic impact of Silvia Galora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Galora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Galora more than expected).

Fields of papers citing papers by Silvia Galora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Galora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Galora. The network helps show where Silvia Galora may publish in the future.

Co-authorship network of co-authors of Silvia Galora

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Galora. A scholar is included among the top collaborators of Silvia Galora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Galora. Silvia Galora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 4
2 53
3 29
4 8
5 22
6 9
7 18
8 1
9 14

About Silvia Galora

Silvia Galora is a scholar working on Biochemistry, Geriatrics and Gerontology and Cardiology and Cardiovascular Medicine, having authored 9 papers that have together received 158 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Connective tissue disorders research (2 papers). The work is most often cited by research in Internal Medicine (12 citations), Cardiology and Cardiovascular Medicine (42 citations) and Ophthalmology (16 citations). Silvia Galora has collaborated with scholars based in Italy. Frequent co-authors include Claudia Saracini, Betti Giusti, Giacomo Emmi, Claudia Fiorillo, Matteo Becatti, Alessandra Bettiol, Flavia Rita Argento, Irene Mattioli, Carlo Pratesi and Giovanni Pratesi. Their work appears in journals such as Journal of Vascular Surgery, Atherosclerosis and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026